y Roche Holding Ltd., of Basel, Switzerland, has raised its stake inGenentech Inc.'s (NYSE:GNE) redeemable common stock to 16percent, or 7,724,700 shares, from 13.54 percent or 6,515,500 shares.The shares were purchased from April 22 to April 26 for $49 to $50 ashare for a total of $60.4 million. Redeemable common shares arethose that may be purchased on the market. Roche already holds 100percent of all Genentech's common stock. The latest acquisition bringsRoche's total stake in the South San Francisco company to 64.93percent of total shares.

(c) 1997 American Health Consultants. All rights reserved.